MedTrace Logo

Pilot Study of Oligonol Supplementation to Promote Cardiovascular Health

NCT01162174 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2010-07-14

No results posted yet for this study

Summary

The investigators hypothesize that acute consumption of Oligonol, a patented lychee fruit extract (Amino Up Chemical Co.) particularly rich in low molecular weight flavanols, will improve endothelial function, reduce platelet reactivity and increase circulating levels of flavonoids after a single intake.

Conditions

  • Cardiovascular Health

Interventions

DIETARY_SUPPLEMENT

Oligonol

Sponsors & Collaborators

  • Amino Up Chemical Company

    collaborator INDUSTRY

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Robert M Hackman, PhD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-02-28
Completion
2009-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01162174 on ClinicalTrials.gov